Optimization and analysis of a grounded type dynamic vibration absorber with lever component

por Shen, Yongjun, Xing, Zikang, Yang, Shaopu, Li, Xianghong
Publicado 2020

Both IDO1 and TDO contribute to the malignancy of gliomas via the Kyn–AhR–AQP4 signaling pathway

por Du, Lisha, Xing, Zikang, Tao, Bangbao, Li, Tianqi, Yang, Dan, Li, Weirui, Zheng, Yuanting, Kuang, Chunxiang, Yang, Qing
Publicado 2020

What is the prospect of indoleamine 2,3-dioxygenase 1 inhibition in cancer? Extrapolation from the past

por Yao, Yu, Liang, Heng, Fang, Xin, Zhang, Shengnan, Xing, Zikang, Shi, Lei, Kuang, Chunxiang, Seliger, Barbara, Yang, Qing
Publicado 2021

Correction: Both IDO1 and TDO contribute to the malignancy of gliomas via the Kyn–AhR–AQP4 signaling pathway

por Du, Lisha, Xing, Zikang, Tao, Bangbao, Li, Tianqi, Yang, Dan, Li, Weirui, Zheng, Yuanting, Kuang, Chunxiang, Yang, Qing
Publicado 2021

Amyloid β neurotoxicity is IDO1–Kyn–AhR dependent and blocked by IDO1 inhibitor

por Duan, Zhenzhen, Zhang, Shengnan, Liang, Heng, Xing, Zikang, Guo, Leilei, Shi, Lei, Du, Lisha, Kuang, Chunxiang, Takikawa, Osamu, Yang, Qing
Publicado 2020

H(2)S suppresses indoleamine 2, 3-dioxygenase 1 and exhibits immunotherapeutic efficacy in murine hepatocellular carcinoma

por Yang, Dan, Li, Tianqi, Li, Yinlong, Zhang, Shengnan, Li, Weirui, Liang, Heng, Xing, Zikang, Du, Lisha, He, Jinchao, Kuang, Chunxiang, Yang, Qing
Publicado 2019

Forty‐three key gene expressions involved in the effect of indoleamine 2,3‐dioxygenase 1 expression on cancer prognosis may be a potential indoleamine 2,3‐dioxygenase 1 inhibitor b...

por Li, Weirui, Guo, Leilei, Xing, Zikang, Fang, Xin, Liang, Heng, Zhang, Shengnan, Shi, Lei, Kuang, Chunxiang, Shi, Leming, Zheng, Yuanting, Hu, Yueqing, Yang, Qing
Publicado 2021